Cargando…

Correction to: Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy

Detalles Bibliográficos
Autores principales:	Bai, Yun-Fei, Chiu, Michelle, Chan, Elizabeth S., Axerio-Cilies, Peter, Lu, Jie, Huh, Linda, Connolly, Mary B., Guella, Ilaria, Farrer, Matthew J., Xu, Zhi-Qing David, Liu, Lidong, Demos, Michelle, Wang, Yu Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102430/ https://www.ncbi.nlm.nih.gov/pubmed/32220239 http://dx.doi.org/10.1186/s13041-020-00593-6

Ejemplares similares

Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy
por: Bai, Yun-Fei, et al.
Publicado: (2019)

Distinct Functional Alterations and Therapeutic Options of Two Pathological De Novo Variants of the T292 Residue of GABRA1 Identified in Children with Epileptic Encephalopathy and Neurodevelopmental Disorders
por: Chen, Wenlin, et al.
Publicado: (2022)

Epileptic Encephalopathies with Status Epilepticus during Sleep: New Techniques for Understanding Pathophysiology and Therapeutic Options
por: Brazzo, Daniela, et al.
Publicado: (2012)

Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse*
por: Yu, Wenxi, et al.
Publicado: (2020)

A standardized polyherbal preparation POL-6 diminishes alcohol withdrawal anxiety by regulating Gabra1, Gabra2, Gabra3, Gabra4, Gabra5 gene expression of GABA(A) receptor signaling pathway in rats
por: Sharma, Lalit, et al.
Publicado: (2021)

Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options
por: Elwir, Saleh, et al.
Publicado: (2017)

A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype
por: Vogel, Florian D., et al.
Publicado: (2022)

Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss‐of‐function variant
por: Gjerulfsen, Cathrine E., et al.
Publicado: (2023)

Epileptic Encephalopathy
por: Specchio, Nicola, et al.
Publicado: (2012)

Epileptic Encephalopathies: An Overview
por: Khan, Sonia, et al.
Publicado: (2012)

Epileptic Encephalopathies in Children
por: Tabarki, Brahim, et al.
Publicado: (2013)

De novo FGF12 mutation in 2 patients with neonatal-onset epilepsy
por: Guella, Ilaria, et al.
Publicado: (2016)

Advances toward precision therapeutics for developmental and epileptic encephalopathies
por: Bertocchi, Ilaria, et al.
Publicado: (2023)

The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis
por: Gumireddy, Kiranmai, et al.
Publicado: (2016)

SCN1B‐linked early infantile developmental and epileptic encephalopathy
por: Aeby, Alec, et al.
Publicado: (2019)

Epileptic Encephalopathies in Adults and Childhood
por: Kural, Zekiye, et al.
Publicado: (2012)

Early infantile epileptic encephalopathies
por: Fois, Alberto
Publicado: (2014)

Ketogenic Diet in Epileptic Encephalopathies
por: Sharma, Suvasini, et al.
Publicado: (2013)

Metabolic Causes of Epileptic Encephalopathy
por: Yu, Joe Yuezhou, et al.
Publicado: (2013)

Inherited Developmental and Epileptic Encephalopathies
por: Bartolini, Emanuele
Publicado: (2021)

Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review
por: Frederick, Aliya, et al.
Publicado: (2020)

The mycobacterial antibiotic resistance determinant WhiB7 acts as a transcriptional activator by binding the primary sigma factor SigA (RpoV)
por: Burian, Ján, et al.
Publicado: (2013)

Surgical Treatment of Pediatric Epileptic Encephalopathies
por: Fridley, J., et al.
Publicado: (2013)

Diagnosis and Management of Epileptic Encephalopathies in Children
por: Jain, Puneet, et al.
Publicado: (2013)

Vitamin-Responsive Epileptic Encephalopathies in Children
por: Agadi, Satish, et al.
Publicado: (2013)

KCNA2-Related Epileptic Encephalopathy
por: Kearney, Jennifer A.
Publicado: (2015)

Neuromonitoring in Neonatal-Onset Epileptic Encephalopathies
por: Trollmann, Regina
Publicado: (2021)

Tubulinopathy Presenting as Developmental and Epileptic Encephalopathy
por: Hung, Kun-Long, et al.
Publicado: (2022)

X linked Infantile Epileptic Encephalopathy due to SMC1A Truncating Mutation
por: Naik, Neeta Ajit, et al.
Publicado: (2021)

Neural bases for attenuation of morphine withdrawal by Heantos-4: role of l-tetrahydropalmatine
por: Ahn, Soyon, et al.
Publicado: (2020)

SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy
por: Vlaskamp, Danique R.M., et al.
Publicado: (2019)

Phenotypic variability of GABRA1‐related epilepsy in monozygotic twins
por: Krenn, Martin, et al.
Publicado: (2019)

Gabra2 is a genetic modifier of Dravet syndrome in mice
por: Hawkins, Nicole A., et al.
Publicado: (2021)

GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility
por: Zeng, Youjie, et al.
Publicado: (2022)

Glutamate and GABA(A) receptor crosstalk mediates homeostatic regulation of neuronal excitation in the mammalian brain
por: Wen, Ya, et al.
Publicado: (2022)

GABRA2 rs279858-linked variants are associated with disrupted structural connectome of reward circuits in heroin abusers
por: Sun, Yan, et al.
Publicado: (2018)

De novo mutations in the classic epileptic encephalopathies
Publicado: (2013)

A Timely Review of the Genetics of Epileptic Encephalopathies
por: Freeman, Jeremy L.
Publicado: (2015)

FHF1 (FGF12) epileptic encephalopathy
por: Al-Mehmadi, Sameer, et al.
Publicado: (2016)

Epileptic Encephalopathy and Autism: A Complex Interplay
por: Chepure, Ashish H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ije3fpksqdldvv1lfvjaevneo